Navigation Links


Vaxfectin in Medical Technology

Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine

SAN FRANCISCO, April 11, 2007 /PRNewswire-FirstCall/ -- Vical Incorporated today announced that a seasonal influenza vaccine formulated with the company's Vaxfectin(TM) adjuvant generated up to 60-fold higher antibody responses than an unformulated vaccine at the same dose in a recently completed ...

Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues

MALAGA, Spain, May 23, 2007 /PRNewswire-FirstCall/ -- Vical Incorporated today announced that in a recently completed animal study, a DNA vaccine formulated with the company's patented Vaxfectin(TM) adjuvant and delivered by needle-free injection yielded significantly higher antibody responses tha...

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... LAS VEGAS, Dec. 11 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced that the company's vaxfectin (R)-formulated H5N1 pandemic influenza DNA vaccines induced T-cell responses against a matching strain of influenza virus and demonstrated cross-cla...
Vaxfectin in other areas

Vical : Products : Infectious Diseases : Influenza

Vical : Shaping the ... Vaxfectin® formulations have demonstrated safety and adjuvant ... addition, studies of Vaxfectin®-formulated pDNA vaccines ...

Vical : Technology : Publications

Vical : Shaping the ... Vaxfectin enhances the humoral immune response to plasmid DNA ... Vaxfectin enhances antigen specific antibody titers and ...

=> Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza ...

Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant VICAL ... injection, the Vaxfectin(TM)-formulated vaccine ...

Vical: Vaxfectin-formulated Measles DNA vaccine elicits long-term ...

Co announces that a measles DNA vaccine formulated with the co's Vaxfectin adjuvant elicited protective levels of neutralizing antibodies in juvenile (1-2 year old) ...
Other TagsHygiene
(Date:11/27/2009).... 27 The Gymboree Corpor...t, CFO/COO, will present at the NASDAQ OMX 23rd In... Hotel in London, England, on Wednesday, December ...ive broadcast of The Gymboree Corporation,s presen...boree.com, click on "Our Company" at the bottom of...
(Date:11/27/2009)...emission vehicles may reduce future disease burden...ealthDay News) -- Encouraging city dwellers to wal...ch greater public health benefits than increased u...e found. , The study compared the projected hea...sport scenarios for London, England, and Delhi, In...
(Date:11/27/2009)...cialist manufacturers who use medical load cells a...of dollars by bringing in technology partner Flint... of pro-active medical manufacturers are calling i...f their projects, ensuring that progress will not ...entially outdated technology. , ...
(Date:11/26/2009)...g tetrathiomolybdate (TM) has been shown in studie...se, a disease caused by an overload of copper, and...ery little, however, is known about how the drug w...y Northwestern University researchers now has prov...ucture of TM bound to copper-loaded metallochapero...
(Date:11/26/2009)...earch Triangle Dental (RTDental), a leading dental...nnounced the expansion of its services to include ...g Macmillan. , Durham,... to announce that Dr. Doug Macmillan, an experienc...tional advanced training seminar. RTDental’...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
(Date:11/24/2009)...he atomic-level action of a remarkable class of ri...earchers with the Lawrence Berkeley National Labor...ein crystallography beamline at the Advanced Light...oles in gene expression and replication, and are v...ell as infectious agents, such as the human papill...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- The...ay a report revealing that the last remaining popu...ificantly due to the rising tide of poaching and h...ill help inform Russian officials of what needs to...orld,s biggest cat. , The report wa...
(Date:11/24/2009)...What constitutes fish food is a matter of debate. ...t fish get almost 50 percent of their carbon from ...etween the terrestrial and aquatic ecosystems. , ...n shows this is not likely to be true. Algae provi...ife, according to research published this week in ...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer 61298 1Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer 61298 2Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer 61298 3Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer 61298 4Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer 61298 5Cornerstone Therapeutics Appoints General Counsel 61296 1Cornerstone Therapeutics Appoints General Counsel 61296 2Cornerstone Therapeutics Appoints General Counsel 61296 3SemBioSys announces third quarter 2009 financial and operational results 14828 1SemBioSys announces third quarter 2009 financial and operational results 14828 2SemBioSys announces third quarter 2009 financial and operational results 14828 3SemBioSys announces third quarter 2009 financial and operational results 14828 4SemBioSys announces third quarter 2009 financial and operational results 14828 5SemBioSys announces third quarter 2009 financial and operational results 14828 6SemBioSys announces third quarter 2009 financial and operational results 14828 7SemBioSys announces third quarter 2009 financial and operational results 14828 8SemBioSys announces third quarter 2009 financial and operational results 14828 9SemBioSys announces third quarter 2009 financial and operational results 14828 10SemBioSys announces third quarter 2009 financial and operational results 14828 11SemBioSys announces third quarter 2009 financial and operational results 14828 12SemBioSys announces third quarter 2009 financial and operational results 14828 13SemBioSys announces third quarter 2009 financial and operational results 14828 14
Other Contentsinsipidusnephroticneuroblastomaneuroblastomaneuroblastomaneuroblastomaneurogenicneurologicalneurologicalneurologicalneurologicalneurologicalneurologicalneurologicalneurologicalneurological